Diagnósticos da América Past Earnings Performance
Past criteria checks 0/6
Diagnósticos da América's earnings have been declining at an average annual rate of -58.2%, while the Healthcare industry saw earnings growing at 21.6% annually. Revenues have been growing at an average rate of 23.4% per year.
Key information
-58.2%
Earnings growth rate
-51.7%
EPS growth rate
| Healthcare Industry Growth | 11.6% |
| Revenue growth rate | 23.4% |
| Return on equity | -9.9% |
| Net Margin | -5.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Some Diagnósticos da América S.A. (BVMF:DASA3) Shareholders Look For Exit As Shares Take 27% Pounding
Nov 15
Diagnósticos da América (BVMF:DASA3) Has Some Way To Go To Become A Multi-Bagger
Nov 13Revenues Working Against Diagnósticos da América S.A.'s (BVMF:DASA3) Share Price Following 27% Dive
Aug 15Diagnósticos da América (BVMF:DASA3) Use Of Debt Could Be Considered Risky
Jul 23Benign Growth For Diagnósticos da América S.A. (BVMF:DASA3) Underpins Stock's 30% Plummet
Jun 24Why Investors Shouldn't Be Surprised By Diagnósticos da América S.A.'s (BVMF:DASA3) 25% Share Price Plunge
May 10Risks To Shareholder Returns Are Elevated At These Prices For Diagnósticos da América S.A. (BVMF:DASA3)
Mar 21Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Feb 04Is Diagnósticos da América (BVMF:DASA3) A Risky Investment?
Jan 08Insufficient Growth At Diagnósticos da América S.A. (BVMF:DASA3) Hampers Share Price
Dec 18Diagnósticos da América (BVMF:DASA3) Is Reinvesting At Lower Rates Of Return
Sep 20Is Diagnósticos da América (BVMF:DASA3) Using Too Much Debt?
Aug 25Diagnósticos da América S.A. (BVMF:DASA3) Looks Inexpensive But Perhaps Not Attractive Enough
Jun 27Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Apr 17Diagnósticos da América (BVMF:DASA3) Seems To Be Using A Lot Of Debt
Mar 13Returns On Capital At Diagnósticos da América (BVMF:DASA3) Paint A Concerning Picture
Dec 14Does Diagnósticos da América (BVMF:DASA3) Have A Healthy Balance Sheet?
Nov 09Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Aug 19Here's Why Diagnósticos da América (BVMF:DASA3) Has A Meaningful Debt Burden
Jul 15Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
May 06Results: Diagnósticos da América S.A. Delivered A Surprise Loss And Now Analysts Have New Forecasts
Apr 01These 4 Measures Indicate That Diagnósticos da América (BVMF:DASA3) Is Using Debt Reasonably Well
Mar 02Diagnósticos da América (BVMF:DASA3) Could Be Struggling To Allocate Capital
Jan 25Diagnósticos da América (BVMF:DASA3) Might Be Having Difficulty Using Its Capital Effectively
Oct 10Is Diagnósticos da América (BVMF:DASA3) A Risky Investment?
Sep 13There Are Reasons To Feel Uneasy About Diagnósticos da América's (BVMF:DASA3) Returns On Capital
Jun 27Diagnósticos da América (BVMF:DASA3) Has A Somewhat Strained Balance Sheet
May 31We're Watching These Trends At Diagnósticos da América (BVMF:DASA3)
Feb 25Shareholders of Diagnósticos da América (BVMF:DASA3) Must Be Delighted With Their 634% Total Return
Jan 03
These 4 Measures Indicate That Diagnósticos da América (BVMF:DASA3) Is Using Debt Extensively
Dec 07Revenue & Expenses Breakdown
How Diagnósticos da América makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 14,971 | -879 | 2,937 | 0 |
| 30 Jun 24 | 14,771 | -972 | 2,947 | 0 |
| 31 Mar 24 | 14,446 | -1,150 | 2,987 | 0 |
| 31 Dec 23 | 14,252 | -1,138 | 2,975 | 0 |
| 30 Sep 23 | 14,213 | -843 | 3,044 | 0 |
| 30 Jun 23 | 13,869 | -752 | 2,762 | 0 |
| 31 Mar 23 | 13,527 | -590 | 2,746 | 0 |
| 31 Dec 22 | 13,129 | -387 | 2,864 | 0 |
| 30 Sep 22 | 12,523 | -340 | 2,930 | 0 |
| 30 Jun 22 | 11,862 | -177 | 2,814 | 0 |
| 31 Mar 22 | 11,178 | -177 | 3,136 | 0 |
| 31 Dec 21 | 10,419 | -227 | 3,066 | 0 |
| 30 Sep 21 | 9,973 | -36 | 3,105 | 0 |
| 30 Jun 21 | 9,280 | -60 | 2,736 | 0 |
| 31 Mar 21 | 7,959 | -85 | 1,997 | 0 |
| 31 Dec 20 | 7,039 | -151 | 1,635 | 0 |
| 30 Sep 20 | 5,887 | -191 | 1,269 | 0 |
| 30 Jun 20 | 4,986 | -198 | 1,271 | 0 |
| 31 Mar 20 | 4,795 | -19 | 1,249 | 0 |
| 31 Dec 19 | 4,365 | 125 | 1,148 | 0 |
| 30 Sep 19 | 4,238 | 127 | 1,129 | 0 |
| 30 Jun 19 | 4,096 | 158 | 1,097 | 0 |
| 31 Mar 19 | 3,992 | 168 | 1,070 | 0 |
| 31 Dec 18 | 3,933 | 184 | 1,046 | 0 |
| 30 Sep 18 | 3,886 | 210 | 899 | 0 |
| 30 Jun 18 | 3,733 | 175 | 875 | 0 |
| 31 Mar 18 | 3,545 | 136 | 841 | 0 |
| 31 Dec 17 | 3,399 | 131 | 823 | 0 |
| 30 Sep 17 | 3,259 | 129 | 791 | 0 |
| 30 Jun 17 | 3,178 | 152 | 715 | 0 |
| 31 Mar 17 | 3,138 | 169 | 665 | 0 |
| 31 Dec 16 | 3,041 | 95 | 652 | 0 |
| 30 Sep 16 | 2,965 | 90 | 596 | 0 |
| 30 Jun 16 | 2,899 | 39 | 592 | 0 |
| 31 Mar 16 | 2,864 | 29 | 606 | 0 |
| 31 Dec 15 | 2,794 | 24 | 605 | 0 |
| 30 Sep 15 | 2,731 | 4 | 604 | 0 |
| 30 Jun 15 | 2,731 | 38 | 610 | 0 |
| 31 Mar 15 | 2,691 | 58 | 588 | 0 |
| 31 Dec 14 | 2,698 | 88 | 576 | 0 |
| 30 Sep 14 | 2,666 | 135 | 604 | 0 |
| 30 Jun 14 | 2,584 | 127 | 564 | 0 |
| 31 Mar 14 | 2,528 | 130 | 532 | 0 |
| 31 Dec 13 | 2,448 | 125 | 490 | 0 |
Quality Earnings: DASA3 is currently unprofitable.
Growing Profit Margin: DASA3 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DASA3 is unprofitable, and losses have increased over the past 5 years at a rate of 58.2% per year.
Accelerating Growth: Unable to compare DASA3's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DASA3 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (64.3%).
Return on Equity
High ROE: DASA3 has a negative Return on Equity (-9.95%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 05:26 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Diagnósticos da América S.A. is covered by 26 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Bertan | BB Banco de Investimento S.A. |
| Flavio Yoshida | BofA Global Research |
| Fred Mendes | BofA Global Research |